D. J. Barnes
Genetics · 2007
A researcher in the Science corpus: 1 paper; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Genetics — 16 citations into it
- Molecular Biology — 11 citations into it
- Cancer Research — 5 citations into it
- Pathology and Forensic Medicine — 5 citations into it
Whom D. J. Barnes trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from D. J. Barnes's perspective
Ordered by how strongly the researchers D. J. Barnes trusts endorse each paper. Same corpus, a different order for every researcher.
- Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. (New England Journal of Medicine)
- A role for Wnt signalling in self-renewal of haematopoietic stem cells (Nature)
- Gene expression changes associated with progression and response in chronic myeloid leukemia. (Proceedings of the National Academy of Sciences of the United States of America)
- Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL. (New England Journal of Medicine)
- The molecular biology of chronic myeloid leukemia. (Blood)
- Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. (New England Journal of Medicine)
- Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. (New England Journal of Medicine)
- Genome maintenance mechanisms for preventing cancer (Nature)
- Multiple mutations and cancer (Proceedings of the National Academy of Sciences of the United States of America)
- The biology of CML blast crisis. (Blood)
Their papers
- Chronic myeloid leukaemia as a model of disease evolution in human cancer (2007) — 616 citations